Research output per year
Research output per year
Project Details
Description
Triple negative breast cancer is defined as a tumor subtype characterized by the lack of expression of hormone receptors for estrogen and progesterone, and human epidermal growth factor receptor 2 (HER2)are considered to be biologically aggressive with higher rates of distant and visceral metastasis.
Objective: to describe the outcomes of patients with triple-negative breast cancer according to treatment and stage at the time of diagnosis in the population attended Mederi Hospital
Objective: to describe the outcomes of patients with triple-negative breast cancer according to treatment and stage at the time of diagnosis in the population attended Mederi Hospital
| Status | Finished |
|---|---|
| Effective start/end date | 22/08/19 → 22/12/20 |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Keywords
- Triple negative breast cancer
- clinical outcomes
- Neoadjuvant
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Research output
- 1 Commissioned report
-
Desenlaces clínicos en pacientes tratadas por cáncer de mama subtipo triple negativo, Hospital Mayor Mederi 2014-2018
Translated title of the contribution :Clinical outcomes in patients treated for triple negative subtype breast cancer, Hospital Mayor Mederi 2014-2018 Research output: Book/Report › Commissioned report